Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Tucci

Showing results (51-60 of 154) with videos related to

Pageof 16
Sort By:
The American Journal of Surgical Pathology|June 3, 2021
E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell NeoplasmLuisa Lorenzi, Silvia Lonardi, Donatella Vairo, et al.
Bone Marrow Transplantation|August 28, 2023
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMTJia Chen, Myriam Labopin, Thomas Pabst, et al.
Leukemia & Lymphoma|September 18, 2015
A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphomaStefano Luminari, Maria Goldaniga, Marina Cesaretti, et al.
Blood Cancer Journal|December 21, 2023
Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?Carlotta Giupponi, Diego Bertoli, Erika Borlenghi, et al.
Hematological Oncology|February 14, 2023
COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantationLorenzo Masina, Nicola Bianchetti, Angela Passi, et al.
Hematological Oncology|February 15, 2022
The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in EuropeMark Bishton, Scott Marshall, Jatinder Harchowal, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 11, 2021
Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experienceVittorio Ruggero Zilioli, Domenico Albano, Annalisa Arcari, et al.
BMC Cancer|August 25, 2025
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatmentStephanie Herold, Christian Schmidt, Carlo Visco, et al.
Cancers|February 27, 2026
Autologous Stem Cell Transplantation in HIV-Positive and HIV-Negative Patients with Lymphoma: A Propensity Score-Matched Comparative AnalysisAlessandro Re, Margherita Oberti, Armando Stabile, et al.
Tumori|February 21, 2017
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelinesSara Pedretti, Mauro Urpis, Carla Leali, et al.
Pageof 16

Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
The American Journal of Surgical Pathology|June 3, 2021
E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell NeoplasmLuisa Lorenzi, Silvia Lonardi, Donatella Vairo, et al.
Bone Marrow Transplantation|August 28, 2023
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMTJia Chen, Myriam Labopin, Thomas Pabst, et al.
Leukemia & Lymphoma|September 18, 2015
A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphomaStefano Luminari, Maria Goldaniga, Marina Cesaretti, et al.
Blood Cancer Journal|December 21, 2023
Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?Carlotta Giupponi, Diego Bertoli, Erika Borlenghi, et al.
Hematological Oncology|February 14, 2023
COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantationLorenzo Masina, Nicola Bianchetti, Angela Passi, et al.
Hematological Oncology|February 15, 2022
The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in EuropeMark Bishton, Scott Marshall, Jatinder Harchowal, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 11, 2021
Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experienceVittorio Ruggero Zilioli, Domenico Albano, Annalisa Arcari, et al.
BMC Cancer|August 25, 2025
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatmentStephanie Herold, Christian Schmidt, Carlo Visco, et al.
Cancers|February 27, 2026
Autologous Stem Cell Transplantation in HIV-Positive and HIV-Negative Patients with Lymphoma: A Propensity Score-Matched Comparative AnalysisAlessandro Re, Margherita Oberti, Armando Stabile, et al.
Tumori|February 21, 2017
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelinesSara Pedretti, Mauro Urpis, Carla Leali, et al.
Pageof 16